Moon or Doom: Will Bitcoin See Fireworks on July 4?
Will Bitcoin close the week above $108,000? The odds on the Myriad prediction market have swung dramatically. Source link
-
-
Cloudflare Hits the Kill Switch on AI Crawlers—And an Entire Industry Cheers
The world’s largest internet security provider just defaulted to blocking AI crawlers—and lets publishers set a price for scraping. Source link
-
Paging Dr. Algorithm: Microsoft’s AI Diagnoses Like House, Bills Like Costco
In head-to-head tests, Microsoft’s virtual medical council diagnosed correctly four times more often than human doctors, and at a lower cost. Source link
-
Solana Skyrockets as Bitcoin and Ethereum Grind Higher: Where Do Prices Go Next?
Bitcoin and Ethereum are climbing upwards, but Solana is outperforming. What’s next for its price? Here’s what the charts say. Source link
-
Can China’s MiniMax-M1 AI Topple US Rivals? We Put It to the Test
We break down China’s new open-source reasoning model, MiniMax-M1: real benchmarks, hidden tradeoffs, and how it stacks up against competitors. Source link
-
Moon or Doom: Where Does Bitcoin Go Next, $115K or $95K?
What’s next for the price of Bitcoin? Prediction markets show growing bullish sentiment despite technical indicators suggesting caution. Source link
-
Moon or Doom: Where Does Ethereum Go Next?
Ethereum sits at a crossroads as traders debate whether the second-largest cryptocurrency will finally break through $3,000 or plunge back down to $2,000. Source link
-
Google’s AlphaGenome AI Makes DNA Readable—And It’s on GitHub
AlphaGenome, accessible via API, cracks the “junk DNA” code, outperforms top rivals in key tests, and puts advanced genomics tools within reach of labs around...
-
Bitcoin Cash Breaks Out, Cardano Breaks Down as Crypto Traders Hold Breath on Fed: Analysis
Bitcoin Cash breaks key resistance amid renewed demand while Cardano tests critical support levels in sideways market conditions. Source link
-
Ozempic’s Newest Miracle: Dramatically Cutting Dementia Risk
New research tracking 1.7 million diabetics shows the weight-loss drug slashes dementia risk by up to 70%. Source link
